Jesse L Yedinak1, Elizabeth N Kinnard1, Scott E Hadland2,3, Traci C Green1,4,5, Melissa A Clark1,6, Brandon D L Marshall1. 1. Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island. 2. Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts. 3. Department of Pediatrics, Harvard Medical School, Boston, Massachusetts. 4. Department of Emergency Medicine, The Warren Alpert School of Brown University, Providence, Rhode Island. 5. Department of Emergency Medicine, Boston University School of Medicine, Boston, Massachusetts. 6. Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts.
Abstract
BACKGROUND AND OBJECTIVES: This pilot study examined the context of nonmedical prescription opioid (NMPO) use and related risk behaviors among young adults in Rhode Island, a New England region with markedly high prevalence of NMPO use and overdose mortality. METHODS: We conducted semi-structured interviews (n = 13) with young adults (18-29 year-olds) who reported current or recent NMPO use. We also conducted focus groups (two groups, n = 14 total) with professional service providers recruited from service organizations. Data were audio-recorded, transcribed, and key themes were analyzed. RESULTS: Participants discussed high levels of access to prescription opioids for nonmedical use via prescriptions originally provided to family and friends. The contexts described by participants included social environments such as parties, in which mixing opiates with benzodiazepines, alcohol or other types of drugs, and incidents of unintentional overdose were reported. Participants attributed risk for overdose to individual-level factors (eg, users who "couldn't handle it"), rather than contextual factors, and described negative reactions to being labeled as an "addict" or "addicted." Professional service providers had first-hand experience with young adults in treatment settings, yet limited exposure to young adults who were treatment-naïve. CONCLUSIONS: Young adult NMPO users described social settings where polysubstance use and pill use were common, and highlighted an aversion to being labeled as having a substance use disorder. SCIENTIFIC SIGNIFICANCE: To reduce harms of NMPO use among young adults, interventions should address the social context in which drug use and risk behaviors occur. (Am J Addict 2016;25:659-665).
BACKGROUND AND OBJECTIVES: This pilot study examined the context of nonmedical prescription opioid (NMPO) use and related risk behaviors among young adults in Rhode Island, a New England region with markedly high prevalence of NMPO use and overdose mortality. METHODS: We conducted semi-structured interviews (n = 13) with young adults (18-29 year-olds) who reported current or recent NMPO use. We also conducted focus groups (two groups, n = 14 total) with professional service providers recruited from service organizations. Data were audio-recorded, transcribed, and key themes were analyzed. RESULTS:Participants discussed high levels of access to prescription opioids for nonmedical use via prescriptions originally provided to family and friends. The contexts described by participants included social environments such as parties, in which mixing opiates with benzodiazepines, alcohol or other types of drugs, and incidents of unintentional overdose were reported. Participants attributed risk for overdose to individual-level factors (eg, users who "couldn't handle it"), rather than contextual factors, and described negative reactions to being labeled as an "addict" or "addicted." Professional service providers had first-hand experience with young adults in treatment settings, yet limited exposure to young adults who were treatment-naïve. CONCLUSIONS: Young adult NMPO users described social settings where polysubstance use and pill use were common, and highlighted an aversion to being labeled as having a substance use disorder. SCIENTIFIC SIGNIFICANCE: To reduce harms of NMPO use among young adults, interventions should address the social context in which drug use and risk behaviors occur. (Am J Addict 2016;25:659-665).
Authors: Tim Rhodes; Merrill Singer; Philippe Bourgois; Samuel R Friedman; Steffanie A Strathdee Journal: Soc Sci Med Date: 2005-03-19 Impact factor: 4.634
Authors: Carlos Blanco; Donald Alderson; Elizabeth Ogburn; Bridget F Grant; Edward V Nunes; Mark L Hatzenbuehler; Deborah S Hasin Journal: Drug Alcohol Depend Date: 2007-05-21 Impact factor: 4.492
Authors: Steffanie A Strathdee; Timothy B Hallett; Natalia Bobrova; Tim Rhodes; Robert Booth; Reychad Abdool; Catherine A Hankins Journal: Lancet Date: 2010-07-24 Impact factor: 79.321
Authors: Montserrat Neira-León; Gregorio Barrio; María J Bravo; M Teresa Brugal; Luis de la Fuente; Antonia Domingo-Salvany; José Pulido; Sara Santos Journal: Int J Drug Policy Date: 2010-08-30
Authors: Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve Journal: MMWR Morb Mortal Wkly Rep Date: 2015-05-01 Impact factor: 17.586
Authors: Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-10 Impact factor: 17.586
Authors: Brandon D L Marshall; Traci C Green; Beth Elston; Jesse L Yedinak; Scott E Hadland; Melissa A Clark Journal: Subst Use Misuse Date: 2018-01-24 Impact factor: 2.164
Authors: Sabriya L Linton; Abigail Winiker; Kayla N Tormohlen; Kristin E Schneider; Grace McLain; Susan G Sherman; Renee M Johnson Journal: Prev Sci Date: 2021-04-07
Authors: Maxwell S Krieger; William C Goedel; Jane A Buxton; Mark Lysyshyn; Edward Bernstein; Susan G Sherman; Josiah D Rich; Scott E Hadland; Traci C Green; Brandon D L Marshall Journal: Int J Drug Policy Date: 2018-10-18